Description of the project

Because of the high cost of artemisinin-based combination therapies (ACTs), people in high-prevalence areas are often forced to buy cheaper anti-malaria medicines that are not effective due to drug resistance. The results are often fatal.

The Affordable Medicines Facility for Malaria (AMFm) is a new initiative that aims to provide affordable, effective and quality-assured ACTs for the public and private sectors in malaria affected countries, with the ultimate goal of pushing substandard and in-effective medicines out of the market. UNITAID is providing a crucial funding commitment to help test out the scheme.

A.	Project title:	Affordable Medicines Facility for Malaria
B.	Timeframe:	Project duration: 2009 - 2012
C.	Amount committed by UNITAID:	US$ 130 000 000
D.	Lead partner:	Global Fund to fight HIV, Tuberculosis and Malaria
E.	Other partner(s):